Insertion Site Analysis

Clonal Analysis. For certain gene therapy clinical trials, the FDA has required post-trial monitoring of patients, evaluating clinical samples for evidence of clonal expansion of cells (PDF). To help academic investigators comply with this FDA recommendation, the NGVB offers assistance with clonal analysis using nrLAM PCR technology. Contact the NGVB Coordinating Center for more information.

SeqMap Informatics Tool. The NGVB also supports analysis of insertion site sequences generated by nrLAM PCR with the SeqMap bioinformatics tool. The tool is available to everyone and can help manage data, as well as search databases and graphically depict insertion sites in relationship to surrounding genes.